Tara L. Kurtis is a member of the Intellectual Property Group. Her practice focuses on patent litigation and prosecution, particularly in the pharmaceutical and biotechnology industries. She has experience handling pharmaceutical patent matters throughout all phases of litigation. A compelling writer, Tara takes complex scientific concepts and presents them in succinct, easily understable terms.

Tara also draws on her litigation experience to bring a unique perspective to her patent prosecution work, which ranges from patent claim drafting to counseling clients on patent landscapes.

Tara gained valuable experience as a 2015 Schiff Hardin summer associate and as a Judicial Extern to the Honorable Amy J. St. Eve in the U.S. District Court for the Northern District of Illinois. Prior to law school, Tara performed laboratory research on nanoparticle drug delivery at Yale University.

  • Credentials


    • University of Illinois College of Law, J.D., 2016, summa cum laude
      Order of the Coif
      Pro Bono Notation
      Illinois Bar Journal Law Update Column, Co-Editor-in-Chief
      University of Illinois Law Review, Admissions Editor
      Hon. St. Eve, U.S. District Court for the Northern District of Illinois, Judicial Extern
    • Yale University, B.S., Biomedical Engineering, 2013, distinction

    Bar Admissions

    • Illinois
        • U.S. Patent and Trademark Office
        • Insights

          News Release

          Schiff Hardin Secures Patent Infringement Win

          Schiff Hardin successfully secured a favorable outcome for our client, Fresenius Kabi USA LLC, in a patent-infringement suit filed by Hospira Inc., which paves the way for Fresenius to market a new generic drug.


          U.S. Pharmaceutical and Biologics Industries Could See Steep Potential Consequences from Texas Judge’s ACA Decision

          In the quick pound of a gavel, the entire U.S. pharmaceutical and biologics industries were thrown into doubt after Judge Reed O’Connor of the United States District Court for the Northern District of Texas found the individual mandate of the Affordable Care Act (ACA) – and therefore the entire act – unconstitutional.


          • “States Hold the Sword to Force ‘Patent Trolls’ Back Under Their Bridges,” University of Illinois Law Review (2016)